Rituximab: A CD20directed cytolytic antibodyvalid until: 23 Jun 2023date published: 23 Jun 2022
Rituximab is a CD20-directed cytolytic antibody, which healthcare professionals use for treating patients with Non–Hodgkin’s Lymphoma (NHL), Chronic Lymphocytic Leukemia (CLL), rheumatoid arthritis, Granulomatosis with Polyangiitis, and Microscopic Polyangiitis (MPA) and moderate to severe pemphigus Vulgaris. The single-dose vials of Rituximab come in 500 mg/50 mL (10 mg/mL) to administer intravenously. Rituximab is produced in Chinese Hamster Ovary suspension culture in a nutrient medium containing the antibiotic gentamicin. It is a genetically engineered chimeric murine/human monoclonal IgG1 kappa antibody directed against the CD20 antigen. Rituximab cost in India is affordable, and one can buy this medicine from several generic medicines. Dial the toll-free no-18008891064 or visit https://theindianpharma.com/buy-reditux-rituximab-online/ for more information about Rituximab.
You may also view these ads: